Apostrophe
Latest round
- Seed
Last raised
- Dec 2019
Total raised
- $6M
Investors
- 3
About Apostrophe
Apostrophe, Inc.Founded in 2012, Apostrophe, Inc. is headquartered in Oakland, US, and focuses on providing personalized skincare solutions. The company was acquired by Hims & Hers Health, Inc. in June 2021 from Nelstone Ventures, FJ Labs, and SignalFire. The acquisition aimed to enhance the delivery of advanced dermatology treatments. Apostrophe's CEO is Ben Holber, who is also one of the co-founders alongside Chris Minnich, Jamaal Young, Linda Nidle, and Ryan Hambley.Apostrophe provides a variety of personalized skincare treatments specifically tailored for women, addressing issues such as wrinkles, acne, dark spots, and overall skin health. Their core offerings consist of customized prescription gel creams along with quality over-the-counter products developed with clinical expertise.Apostrophe operates on a direct-to-consumer model, primarily conducting transactions via their online platform. Products can be purchased individually, starting at USD 15, ensuring easy access to personalized skincare solutions. This model focuses on individual sales rather than subscriptions or partnerships, although bundled offerings may be available.With the acquisition finalized in June 2021, Apostrophe, Inc. plans to leverage the resources of Hims & Hers Health, Inc. to broaden its range of dermatology treatments and enhance service delivery. Future initiatives include the design and launch of new personalized skincare products to meet evolving customer needs. The company aims to expand its market presence beyond North America, targeting specific growth in European and Asian markets by 2023.
Who invested in Apostrophe
3 investors across 3 rounds
See all investors in Apostrophe
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apostrophe
Who invested in Apostrophe?
Apostrophe has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apostrophe raised?
Apostrophe has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Apostrophe last raise money?
Apostrophe's most recent round on record is a Seed, in Dec 2019.
What does Apostrophe do?
Apostrophe is a healthcare specialists company.
Where is Apostrophe headquartered?
Apostrophe is headquartered in Oakland, US.
Which VCs invest in companies like Apostrophe?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Apostrophe's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Apostrophe? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.